
UK cancer-therapy company strikes deal to manufacture CAR-T treatment in Estonia
A London-listed biotech company Hemogenyx Pharmaceuticals has signed a binding agreement with Cellin Technologies, an Estonian cell-therapy

A London-listed biotech company Hemogenyx Pharmaceuticals has signed a binding agreement with Cellin Technologies, an Estonian cell-therapy